logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
J

Janice Wahl

merck & company
H指数:29
被引数:4,636

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Elbasvir/grazoprevir and sofosbuvir for hepatitis C virus genotype 3 infection with compensated cirrhosis: A randomized trial

Elbasvir/grazoprevir和sofosbuvir治疗丙型肝炎病毒基因型3感染并代偿期肝硬化: 一项随机试验

HEPATOLOGY
IF15.8
2018-04-1918
OAAI
Foster, Graham R.; Agarwal, Kosh; Cramp, Matthew E.; Moreea, Sulleman; Barclay, Stephen; Collier, Jane; Brown, Ashley S.; Ryder, Stephen D.; Ustianowski, Andrew; Forton, Daniel M.; Fox, Ray; Gordon, Fiona; Rosenberg, William M.; Mutimer, David J.; Du, Jiejun; Gilbert, Christopher L.; Asante-Appiah, Ernest; Wahl, Janice; Robertson, Michael N.; Barr, Eliav; Haber, Barbara
Elbasvir/Grazoprevir in Asia-Pacific/Russian Participants With Chronic Hepatitis C Virus Genotype 1, 4, or 6 Infection
HEPATOLOGY COMMUNICATIONS
IF4.6
2018-04-0418
OAAI
George, Jacob; Burnevich, Eduard; Sheen, I-Shyan; Heo, Jeong; Nguyen Van Kinh; Tanwandee, Tawesak; Cheng, Pin-Nan; Kim, Do Young; Tak, Won Young; Kizhlo, Svetlana; Zhdanov, Konstantin; Isakov, Vasily; Liang, Liwen; Lindore, Pauline; Ginanni, Joy; Nguyen, Bach-Yen; Wahl, Janice; Barr, Eliav; Robertson, Michael; Ingravallo, Paul; Talwani, Rohit
Safety and efficacy of a fixed-dose combination regimen of grazoprevir, ruzasvir, and uprifosbuvir with or without ribavirin in participants with and without cirrhosis with chronic hepatitis C virus genotype 1, 2, or 3 infection (C-CREST-1 and C-CREST-2, part B): two randomised, phase 2, open-label trials
LANCET GASTROENTEROLOGY & HEPATOLOGY
IF38.6
2017-11-0112
PREAI
Lawitz, Eric; Buti, Maria; Vierling, John M.; Almasio, Piero L.; Bruno, Savino; Ruane, Peter J.; Hassanein, Tarek I.; Muellhaupt, Beat; Pearlman, Brian; Jancoriene, Ligita; Gao, Wei; Huang, Hsueh-Cheng; Shepherd, Aimee; Tannenbaum, Brynne; Fernsler, Doreen; Li, Jerry J.; Grandhi, Anjana; Liu, Hong; Su, Feng-Hsiu; Wan, Shuyan; Dutko, Frank J.; Nguyen, Bach-Yen T.; Wahl, Janice; Robertson, Michael N.; Barr, Eliav; Yeh, Wendy W.; Plank, Rebeca M.; Butterton, Joan R.; Yoshida, Eric M.
Safety and efficacy of an 8-week regimen of grazoprevir plus ruzasvir plus uprifosbuvir compared with grazoprevir plus elbasvir plus uprifosbuvir in participants without cirrhosis infected with hepatitis C virus genotypes 1, 2, or 3 (C-CREST-1 and C-CREST-2, part A): two randomised, phase 2, open-label trials
LANCET GASTROENTEROLOGY & HEPATOLOGY
IF38.6
2017-11-0119
PREAI
Gane, Edward J.; Pianko, Stephen; Roberts, Stuart K.; Thompson, Alexander J.; Zeuzem, Stefan; Zuckerman, Eli; Ben-Ari, Ziv; Foster, Graham R.; Agarwal, Kosh; Laursen, Alex L.; Gerstoft, Jan; Gao, Wei; Huang, Hsueh-Cheng; Fitzgerald, Brian; Fernsler, Doreen; Li, Jerry J.; Grandhi, Anjana; Liu, Hong; Su, Feng-Hsiu; Wan, Shuyan; Zeng, Zhen; Chen, Huei-Ling; Dutko, Frank J.; Nguyen, Bach-Yen T.; Wahl, Janice; Robertson, Michael N.; Barr, Eliav; Yeh, Wendy W.; Plank, Rebeca M.; Butterton, Joan R.; Esteban, Rafael
Elbasvir plus grazoprevir in patients with hepatitis C virus infection and stage 4-5 chronic kidney disease: clinical, virological, and health-related quality-of-life outcomes from a phase 3, multicentre, randomised, double-blind, placebo-controlled trial
LANCET GASTROENTEROLOGY & HEPATOLOGY
IF38.6
2017-08-0175
PREAI
Bruchfeld, Annette; Roth, David; Martin, Paul; Nelson, David R.; Pol, Stanislas; Londono, Maria-Carlota; Monsour, Howard, Jr.; Silva, Marcelo; Hwang, Peggy; Arduino, Jean-Marie; Robertson, Michael; Bach-Yen Nguyen; Wahl, Janice; Barr, Eliav; Greaves, Wayne
HEPATITIS C VIRUS (HCV) REINFECTION AND INJECTION RISK BEHAVIOR FOLLOWING ELBASVIR/GRAZOPREVIR (EBR/GZR) TREATMENT IN PATIENTS ON OPIOID AGONIST THERAPY (OAT): CO-STAR THREE-YEAR FOLLOW-UP STUDY
GASTROENTEROLOGY
IF25.1
2017-04-011
PREAI
Haber, Barbara; Gane, Edward; Dore, Gregory J.; Grebely, Jason; Altice, Frederick; Litwin, Alain H.; Dalgard, Olav; Shibolet, Oren; Luetkemeyer, Anne; Nahass, Ronald; Peng, Cheng-Yuan; Conway, Brian; Iser, David M.; Huang, Hsueh-Cheng; Gendrano, Isaias N.; Kelly, Michelle; Hwang, Peggy; Robertson, Michael; Wahl, Janice; Barr, Eliav; Platt, Heather L.
High sustained virologic response rates in patients with chronic hepatitis C virus GT1, 2 or 3 infection following 16 weeks of MK-3682/grazoprevir/ruzasvir plus ribavirin after having failed 8 weeks of a triplet drug regimen (Part C of C-CREST-1 & 2)
JOURNAL OF HEPATOLOGY
IF33
2017-01-012
PREAI
Serfaty, L.; Pianko, S.; Ari, Z. B.; Laursen, A. L.; Hansen, J.; Gane, E. J.; Huang, H. -C.; Jin, S.; Bourque, J.; Liu, H.; Grandhi, A.; Su, M.; Gendrano, N.; Fernsler, D.; Dutko, F.; Nguyen, B. -Y. T.; Wahl, J.; Barr, E.; Yeh, W.; Plank, R.; Butterton, J. R.
Efficacy and safety of the fixed-dose combination regimen of MK3 [MK-3682/grazoprevir/ruzasvir] with or without ribavirin in non-cirrhotic or cirrhotic patients with chronic HCV GT1, 2, 3, 4 or 6 infection (Parts A & B of C-CREST-1 & 2)
JOURNAL OF HEPATOLOGY
IF33
2017-01-011
PREAI
Lawitz, E.; Yoshida, E. M.; Buti, M.; Vierling, J. M.; Almasio, P. L.; Bruno, S.; Ruane, P. J.; Hassanein, T. I.; Mullhaupt, B.; Pearlman, B.; Jancoriene, L.; Gao, W.; Huang, H. -C.; Shepherd, A.; Tannenbaum, B.; Fernsler, D.; Li, J. J.; Grandhi, A.; Liu, H.; Su, M.; Dutko, F.; Yeh, W. W.; Plank, R.; Nguyen, B. -Y. T.; Wahl, J.; Barr, E.; Butterton, J. R.
Safety and efficacy of the fixed-dose combination regimen of MK-3682/grazoprevir/ruzasvir in cirrhotic or non-cirrhotic patients with chronic HCV GT1 infection who previously failed a direct-acting antiviral regimen (C-SURGE)
JOURNAL OF HEPATOLOGY
IF33
2017-01-013
PREAI
Wedemeyer, H.; Wyles, D.; Reddy, R.; Luetkemeyer, A.; Jacobson, I.; Vierling, J. M.; Gordon, S.; Nahass, R.; Zeuzem, S.; Wahl, J.; Barr, E.; Nguyen, B. -Y. T.; Robertson, M.; Joeng, H. -K.; Liu, H.; Jumes, P.; Dutko, F.; Martin, E.
Efficacy and safety of elbasvir/grazoprevir and sofosbuvir/pegylated interferon/ribavirin: A phase III randomized controlled trial
JOURNAL OF HEPATOLOGY
IF33
2016-12-0142
PREAI
Sperl, Jan; Horvath, Gabor; Halota, Waldemar; Arenas Ruiz-Tapiador, Juan; Streinu-Cercel, Anca; Jancoriene, Ligita; Werling, Klara; Kileng, Hege; Koklu, Seyfettin; Gerstoft, Jan; Urbanek, Petr; Flisiak, Robert; Leiva, Rafael; Kazenaite, Edita; Prinzing, Renate; Patel, Sushma; Qiu, Jingjun; Asante-Appiah, Ernest; Wahl, Janice; Bach-Yen Nguyen; Barr, Eliav; Platt, Heather L.
The combination of elbasvir and grazoprevir for the treatment of chronic HCV infection in Japanese patients: a randomized phase II/III study
JOURNAL OF GASTROENTEROLOGY
IF5.5
2016-11-2174
OAAI
Kumada, Hiromitsu; Suzuki, Yoshiyuki; Karino, Yoshiyasu; Chayama, Kazuaki; Kawada, Norifumi; Okanoue, Takeshi; Itoh, Yoshito; Mochida, Satoshi; Toyoda, Hidenori; Yoshiji, Hitoshi; Takaki, Shintaro; Yatsuzuka, Naoyoshi; Yodoya, Etsuo; Iwasa, Takashi; Fujimoto, Go; Robertson, Michael N.; Black, Stuart; Caro, Luzelena; Wahl, Janice

研究方向

暂未获取到该数据
M
Michael Robertson
H 指数:47论文数:200被引数:1.1万
E
Eliav Barr
H 指数:55论文数:163被引数:2.0万
P
Peggy Hwang
H 指数:23论文数:86被引数:2,066
E
Emily Barr
H 指数:34论文数:136被引数:4,912
F
Frank J. Dutko
H 指数:28论文数:90被引数:4,707
B
Barbara Haber
H 指数:38论文数:183被引数:5,497
J
John M. Vierling
H 指数:66论文数:360被引数:1.8万
E
Edward Gane
H 指数:97论文数:726被引数:5.6万
C
Christophe Hézode
H 指数:69论文数:332被引数:1.8万
L
Lawrence Serfaty
H 指数:66论文数:325被引数:1.7万